Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro
出版年份 2022 全文链接
标题
Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro
作者
关键词
4-Methylumbelliferone, Lung cancer, Nanoencapsulation, Dual targeting, Hybrid polymeric protein
出版物
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-02-21
DOI
10.1016/j.ijbiomac.2022.02.095
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Screening for Lung Cancer With Low-Dose Computed Tomography
- (2021) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
- (2021) Marcelo M. Rodríguez et al. Scientific Reports
- Extraction of chlorophyll and carotenoids loaded into chitosan as potential targeted therapy and bio imaging agents for breast carcinoma
- (2021) Nemany A.N. Hanafy et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy
- (2021) Mengzhu Zhang et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis
- (2021) Qian Li et al. JOURNAL OF CONTROLLED RELEASE
- Towards the Development of a Female Animal Model of T1DM Using Hyaluronic Acid Nanocoated Cell Transplantation: Refinements and Considerations for Future Protocols
- (2021) Fernanda Zamboni et al. Pharmaceutics
- Labile crosslinked hyaluronic acid via urethane formation using bis(β-isocyanatoethyl) disulphide with tuneable physicochemical and immunomodulatory properties
- (2020) Fernanda Zamboni et al. CARBOHYDRATE POLYMERS
- Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone
- (2020) Shiyao Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer
- (2020) Marwa Labib Essa et al. Materials
- Liquid crystalline assembly for potential combinatorial chemo–herbal drug delivery to lung cancer cells
- (2019) Hadeer M. Abdelaziz et al. International Journal of Nanomedicine
- Phthalocyanine-doped polystyrene fluorescent nanocomposite as a highly selective biosensor for quantitative determination of cancer antigen 125
- (2019) M.S. Attia et al. TALANTA
- Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin
- (2018) Sheng Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Effect of natural and modified cyclodextrins on the excited state proton transfer of 7-hydroxy-4-methylcoumarin
- (2018) A. Antony Muthu Prabhu et al. JOURNAL OF MOLECULAR LIQUIDS
- Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors
- (2018) Theodoros T. Karalis et al. MATRIX BIOLOGY
- Dual-targeted nanomedicines for enhanced tumor treatment
- (2018) Yaqin Zhu et al. Nano Today
- Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
- (2017) Kentaro Inamura Frontiers in Oncology
- Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer
- (2016) Cike Peng et al. INTERNATIONAL JOURNAL OF CANCER
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Inflammation has a role in urethane-induced lung cancer in C57BL/6J mice
- (2016) Cai Xu et al. Molecular Medicine Reports
- Hyaluronan in cancer – from the naked mole rat to nanoparticle therapy
- (2016) Kenneth S. Rankin et al. Soft Matter
- PEGylated Polypyrrole Nanoparticles Conjugating Gadolinium Chelates for Dual-Modal MRI/Photoacoustic Imaging Guided Photothermal Therapy of Cancer
- (2015) Xiaolong Liang et al. ADVANCED FUNCTIONAL MATERIALS
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- 4-Methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis
- (2015) Flavia Piccioni et al. GLYCOBIOLOGY
- Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
- (2015) Travis J. Yates et al. JNCI-Journal of the National Cancer Institute
- Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
- (2015) Travis J. Yates et al. JNCI-Journal of the National Cancer Institute
- 4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
- (2015) Nadine Nagy et al. Frontiers in Immunology
- Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
- (2013) Kunn Hadinoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
- (2013) Anish Babu et al. Journal of Nanomaterials
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- (2011) Elisabeth Luporsi et al. BREAST CANCER RESEARCH AND TREATMENT
- Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice
- (2011) F. Piccioni et al. GLYCOBIOLOGY
- Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo
- (2011) Hiroshi Urakawa et al. INTERNATIONAL JOURNAL OF CANCER
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Poly (lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: Cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target
- (2011) Soumya Sundar Bhattacharyya et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Antitumor Activity of Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone in Prostate Cancer Cells
- (2010) Vinata B. Lokeshwar et al. CANCER RESEARCH
- Study on the binding of puerarin to bovine serum albumin by isothermal titration calorimetry and spectroscopic approaches
- (2010) Juqun Xi et al. JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
- TGF-² Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer
- (2010) Hyo-Sung Jeon et al. Journal of Thoracic Oncology
- Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens
- (2010) F. Grossi et al. ONCOLOGIST
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3
- (2009) Anne Kultti et al. EXPERIMENTAL CELL RESEARCH
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles
- (2007) J. Zhang et al. Acta Biomaterialia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More